Suppr超能文献

局部使用羟甲唑啉的全身副作用。

Systemic side effects of locally used oxymetazoline.

作者信息

Dokuyucu Recep, Gokce Hasan, Sahan Mustafa, Sefil Fatih, Tas Zeynel Abidin, Tutuk Okan, Ozturk Atakan, Tumer Cemil, Cevik Cengiz

机构信息

Department of Medical Physiology, School of Medicine, Mustafa Kemal University Hatay, Turkey.

Department of Pathology, School of Medicine, Mustafa Kemal University Hatay, Turkey.

出版信息

Int J Clin Exp Med. 2015 Feb 15;8(2):2674-8. eCollection 2015.

Abstract

OBJECTIVES

The object of the study is to experimentally investigate the possible systemic side effects of Oxymetazoline including its nasal spray which has been in use for a long time both by the physicians and patients. There is no study in the literature to address the damages of oxymetazoline on the end organ.

MATERIALS AND METHODS

The study conducted on 2 groups of rat. Group 1 (n = 8): Control; and Group 2 (n = 8): Oxymetazoline. During 4 week, the control group was applied with 2 drops of saline water on each nasal cavity 3 times a day and the other group was applied with 2 drops of oxymetazoline HCl 3 times a day. At the end of experiment, samples from mandible, parotid and tails of the rats were taken in 10% formalin for histopathological investigations.

RESULTS

In histopathological experiments, when compared with the control group, the oxymetazoline group showed significant increase in many of the histopathological parameters (ischemic changes: P = 0.0001; congestion: P = 0.0006; arterial thrombosis: P = Ns; PNL accumulations: P = 0.001; necrosis: P = 0.0001; and ulceration: P = 0.014). The results of histopathologic tests on the samples taken from mandible and parotid gland, in comparison with the control group, showed no significant increase (focal inflammation: P = Ns; and lymphocyte aggregation: P = Ns).

CONCLUSION

Due to the damage that the long-term use of nasal spray including oxymetazoline, it may cause injury on the end organ, which we revealed in our histopathological experiments. We believe that it's essential for the physicians to provide information on the side effects of the medicine to their patients who use for a long term.

摘要

目的

本研究旨在通过实验探究去氧肾上腺素可能产生的全身副作用,包括其鼻喷雾剂,该药物长期以来一直被医生和患者使用。文献中尚无关于去氧肾上腺素对终末器官损害的研究。

材料与方法

对两组大鼠进行研究。第1组(n = 8):对照组;第2组(n = 8):去氧肾上腺素组。在4周内,对照组每天在每个鼻腔滴注2滴生理盐水,共3次,另一组每天在每个鼻腔滴注2滴盐酸去氧肾上腺素,共3次。实验结束时,取大鼠的下颌骨、腮腺和尾巴样本,用10%福尔马林固定,进行组织病理学检查。

结果

在组织病理学实验中,与对照组相比,去氧肾上腺素组的许多组织病理学参数显著增加(缺血性改变:P = 0.0001;充血:P = 0.0006;动脉血栓形成:P =无显著差异;中性粒细胞聚集:P = 0.001;坏死:P = 0.0001;溃疡形成:P = 0.014)。与对照组相比,取自下颌骨和腮腺的样本的组织病理学检查结果显示无显著增加(局灶性炎症:P =无显著差异;淋巴细胞聚集:P =无显著差异)。

结论

由于长期使用包括去氧肾上腺素在内的鼻喷雾剂会造成损害,我们在组织病理学实验中发现其可能会对终末器官造成损伤。我们认为,医生向长期使用该药物的患者提供药物副作用信息至关重要。

相似文献

1
Systemic side effects of locally used oxymetazoline.
Int J Clin Exp Med. 2015 Feb 15;8(2):2674-8. eCollection 2015.
2
Effect of oxymetazoline nasal spray on intraocular pressure and retrobulbar hemodynamics.
J Otolaryngol. 2006 Feb;35(1):30-5. doi: 10.2310/7070.2005.4102.
4
Premedication Methods in Nasal Endoscopy: A Prospective, Randomized, Double-Blind Study.
Clin Exp Otorhinolaryngol. 2017 Jun;10(2):158-163. doi: 10.21053/ceo.2016.00563. Epub 2016 Jul 27.
7
Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits.
Acta Otolaryngol. 1995 Sep;115(5):664-71. doi: 10.3109/00016489509139384.
10
Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays.
Laryngoscope. 1996 May;106(5 Pt 1):605-9. doi: 10.1097/00005537-199605000-00016.

引用本文的文献

2
A Breath of Relief: Oxymetazoline and Flunisolide Nasal Spray in the Management of Myasthenia Gravis Ptosis.
Cureus. 2024 Apr 23;16(4):e58812. doi: 10.7759/cureus.58812. eCollection 2024 Apr.
4
Challenges in the Development and Application of Organ-on-Chips for Intranasal Drug Delivery Studies.
Pharmaceutics. 2023 May 22;15(5):1557. doi: 10.3390/pharmaceutics15051557.
6
Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System.
Front Pharmacol. 2022 Mar 24;13:865590. doi: 10.3389/fphar.2022.865590. eCollection 2022.
7
Ischemic Stroke Associated with Chronic Xylometazoline Nasal Spray Misuse: A Rare Avoidable Adverse Event.
Ann Indian Acad Neurol. 2021 Mar-Apr;24(2):304-307. doi: 10.4103/aian.AIAN_291_20. Epub 2020 Jul 8.
8
Conceptual Model for Using Imidazoline Derivative Solutions in Pulpal Management.
J Clin Med. 2021 Mar 15;10(6):1212. doi: 10.3390/jcm10061212.
9
Intranasal drug delivery: opportunities and toxicologic challenges during drug development.
Drug Deliv Transl Res. 2022 Apr;12(4):735-757. doi: 10.1007/s13346-020-00891-5. Epub 2021 Jan 25.
10
Sympathomimetic amine compounds and hepatotoxicity: Not all are alike-Key distinctions noted in a short review.
Toxicol Rep. 2018 Dec 1;6:26-33. doi: 10.1016/j.toxrep.2018.11.013. eCollection 2019.

本文引用的文献

1
Determination of oxidative stress and effect of erdosteine on rhinitis medicamentosa in a rat model.
Eur J Pharmacol. 2014 Nov 5;742:153-7. doi: 10.1016/j.ejphar.2014.09.009. Epub 2014 Sep 18.
2
Cerebral vasoconstriction triggered by sympathomimetic drugs during intra-atrerial chemotherapy.
Pediatr Neurol. 2013 Feb;48(2):139-42. doi: 10.1016/j.pediatrneurol.2012.10.005.
3
The local vasoconstriction of infant's skin following instillation of mydriatic eye drops.
Eur J Clin Pharmacol. 2010 Nov;66(11):1161-4. doi: 10.1007/s00228-010-0890-6. Epub 2010 Sep 11.
4
Are nasal decongestants safer than rhinitis? A case of oxymetazoline-induced syncope.
Cardiol Young. 2009 Dec;19(6):633-4. doi: 10.1017/S1047951109990722. Epub 2009 Sep 23.
5
Rhinitis medicamentosa: what an otolaryngologist needs to know.
Eur Arch Otorhinolaryngol. 2009 May;266(5):623-5. doi: 10.1007/s00405-008-0896-1. Epub 2008 Dec 19.
6
Rhinitis medicamentosa.
J Investig Allergol Clin Immunol. 2006;16(3):148-55.
9
Cardiac arrest after oxymetazoline nasal spray.
J Clin Anesth. 1995 Sep;7(6):512-4. doi: 10.1016/0952-8180(95)00060-u.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验